Salvatori Fabio, Macchini Marco, Rosati Marzia, Boscarato Pietro, Alborino Salvatore, Paci Enrico, Candelari Roberto
Interventional Radiology, Ospedale Generale Provinciale di Macerata, Macerata, Italy.
Interventional Radiology, Department of Radiology, Az. Osp-Univ OORR-Torrette, Ancona, Italy.
Urologia. 2022 May;89(2):167-175. doi: 10.1177/03915603211017886. Epub 2021 May 20.
To evaluate the efficacy of endovascular treatment for vascular renal injuries (VRIs) like bleeding, pseudoaneurysm and artero-venous fistula (AVF) and to compare patients with blunt trauma (T-VRIs) with those with iatrogenic damage (I-VRIs).
We retrospectively assessed 49 renal artery embolizations performed to treat T-VRIs (26.5%) and I-VRIs (73.5%). Different embolic materials were used based on the type of lesion. Technical success was defined as the complete occlusion of target arteries with no further visualization of VRIs. Clinical success was defined if no recurrence was present and if renal function (difference between creatinine after and before treatment <0.5 mg/dl) was preserved after 1 month.
Angiography showed bleeding in 27 patients, pseudoaneurysm in 29 and an AVF in 6. Embolic agents used were coils in 39 procedures, coils with sponge in four and others in six. Technical success was 100% while clinical success was 85.7% due to seven patients with recurrence. The group I-VRIs showed a higher rate of clinical success than the group T-VRIs (94.4% vs 61.5%; < 0.05). Moreover, the group I-VRIs had a higher incidence of pseudoaneurysms and AVFs compared with the group T-VRIs (69.4% vs 30.8% and 16.7% vs 0%; < 0.05).
Endovascular treatment for VRIs showed satisfactory results and no patient had a worsening of renal function. I-VRIs had better clinical success and more frequently appeared as pseudoaneurysms compared to T-VRIs: probably iatrogenic injury is localized and pseudoaneurysm is easily identifiable and treatable with endovascular treatment.
评估血管内治疗对血管性肾损伤(VRIs)如出血、假性动脉瘤和动静脉瘘(AVF)的疗效,并比较钝性创伤患者(T-VRIs)和医源性损伤患者(I-VRIs)。
我们回顾性评估了49例为治疗T-VRIs(26.5%)和I-VRIs(73.5%)而进行的肾动脉栓塞术。根据病变类型使用不同的栓塞材料。技术成功定义为目标动脉完全闭塞,VRIs不再显影。如果1个月后无复发且肾功能得以保留(治疗后与治疗前肌酐差值<0.5mg/dl),则定义为临床成功。
血管造影显示27例患者有出血,29例有假性动脉瘤,6例有AVF。39例手术使用了弹簧圈,4例使用了弹簧圈加海绵,6例使用了其他材料。技术成功率为100%,但由于7例患者复发,临床成功率为85.7%。I-VRIs组的临床成功率高于T-VRIs组(94.4%对61.5%;P<0.05)。此外,与T-VRIs组相比,I-VRIs组假性动脉瘤和AVF的发生率更高(69.4%对30.8%以及16.7%对0%;P<0.05)。
血管内治疗VRIs显示出令人满意的结果,且无患者肾功能恶化。与T-VRIs相比,I-VRIs有更好的临床成功率,且更常表现为假性动脉瘤:医源性损伤可能较为局限,假性动脉瘤易于识别且可通过血管内治疗治愈。